Clinical Effects of Xanthine Oxidase Inhibitors in Hyperuricemic Patients
In conclusion, xanthine oxidase inhibitors remain the first choice uric acid lowering drug for chronic treatment.
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research
More News: Allopurinol | Cancer | Cancer & Oncology | Cardiology | Clinical Trials | Databases & Libraries | Heart | Heart Failure | Internal Medicine | Study